We are live on ! Find out more
FLACW

Frazier Lifesciences Acquisition Corporation Warrant
FLACW

Delisted

FLACW was delisted on the 22nd of November, 2022.

Back to rankings

30 hedge funds and large institutions have $1.6M invested in Frazier Lifesciences Acquisition Corporation Warrant in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 30 → 30 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

12% less capital invested

Capital invested by funds: $1.83M → $1.6M (-$228K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
30
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
4
Closed
6
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
-$20K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$20.3K
2
AI
Arena Investors
New York
+$6.45K
3
WAM
Wolverine Asset Management
Illinois
+$5.62K
4
MF
Magnetar Financial
Illinois
+$2.41K
5
OMC
Old Mission Capital
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$27.2K
2
GL
Governors Lane
New York
-$23K
3
PI
PEAK6 Investments
Illinois
-$8K
4
SCM
Suvretta Capital Management
New York
-$7K
5
GCL
Glazer Capital LLC
New York
-$6K

FLACW Hedge Fund Activity: Q2 2022 in Review

30 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Warrant (FLACW) for Q2 2022, worth a combined $1.6M — down 12% from $1.83M a quarter earlier.

Fund positioning in FLACW was balanced in Q2 2022: 6 funds opened new positions, 6 closed out, 1 added to existing stakes and 4 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $20.3K. The largest seller was Citadel Advisors, cutting an estimated $27.2K.

  • 30 institutional investors held Frazier Lifesciences Acquisition Corporation Warrant (FLACW) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $1.6M of Frazier Lifesciences Acquisition Corporation Warrant stock for Q2 2022, down 12% quarter-over-quarter.
  • 6 funds opened new Frazier Lifesciences Acquisition Corporation Warrant positions in Q2 2022 and 6 closed out, a net change of 0 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Warrant buyer in Q2 2022 was Shaolin Capital Management, an estimated $20.3K added.
  • The largest Frazier Lifesciences Acquisition Corporation Warrant seller in Q2 2022 was Citadel Advisors, an estimated $27.2K sold.

Based on aggregated 13F filings for Q2 2022.